Ketorolac

• Ketorolac is a powerful NSAID used for short-term, acute moderate to severe pain.
• It works by inhibiting prostaglandin synthesis, reducing pain and inflammation.
• Available in various forms, including oral, injectable, and ophthalmic, with specific dosage guidelines.
• Significant side effects include gastrointestinal issues, kidney problems, and increased bleeding risk.
• Due to potential risks, its systemic use is strictly limited to five days.

What is Ketorolac and How It Works

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that provides powerful pain relief. It is typically prescribed for acute, moderate to severe pain that requires short-term management, often after surgery or injury. Unlike many other NSAIDs, Ketorolac is available in various formulations, including oral tablets, intravenous (IV) injection, intramuscular (IM) injection, and ophthalmic drops. Its potency makes it a valuable option for pain control, particularly when opioid-sparing strategies are desired.

Ketorolac works in the body by inhibiting the production of prostaglandins, which are lipid compounds that play a crucial role in mediating pain, inflammation, and fever. Specifically, it non-selectively inhibits cyclooxygenase (COX) enzymes, COX-1 and COX-2. COX-1 is involved in maintaining the protective lining of the stomach and kidney function, while COX-2 is primarily responsible for inflammation and pain signals. By blocking these enzymes, Ketorolac reduces the body’s inflammatory response and pain perception.

Ketorolac Uses, Dosage, and Administration

Ketorolac is primarily used for the short-term treatment of moderate to severe acute pain. This often includes post-surgical pain, musculoskeletal injuries, and other conditions where rapid and effective pain relief is needed. It is not intended for chronic pain management due to its potential for serious side effects with prolonged use.

Regarding ketorolac dosage and administration, these vary significantly depending on the route of administration and the patient’s condition. For systemic use (oral, IV, IM), the maximum duration of treatment is typically limited to five days to minimize the risk of adverse events.

• Intravenous (IV) or Intramuscular (IM) Injection: Often used for initial treatment in a hospital setting, common doses range from 15 mg to 30 mg every six hours, not exceeding 120 mg per day.
• Oral Tablets: Once a patient can tolerate oral medication, they may be transitioned to oral Ketorolac at a dose of 10 mg every 4-6 hours, also not exceeding 40 mg per day and maintaining the five-day total treatment limit.
• Ophthalmic Solution: Used for reducing eye pain and inflammation after cataract surgery or corneal procedures, typically one drop four times a day for a limited period.

It is crucial to follow a healthcare provider’s instructions precisely regarding dosage and duration to ensure safety and efficacy.

Ketorolac Side Effects and Warnings

Regarding ketorolac side effects and warnings, these are significant due to its potent nature and mechanism of action. Because it inhibits COX-1, it can interfere with processes vital for maintaining the stomach lining and kidney function, leading to potentially serious adverse effects.

Common side effects may include gastrointestinal upset, such as nausea, indigestion, and abdominal pain; headache and dizziness; and fluid retention and swelling. More serious warnings and potential side effects include:

• Gastrointestinal Bleeding and Ulceration: This is a major concern, especially with prolonged use or in patients with a history of GI issues.
• Kidney Damage: Ketorolac can impair kidney function, particularly in elderly patients, those with pre-existing kidney disease, or individuals who are dehydrated.
• Increased Risk of Cardiovascular Events: Like other NSAIDs, Ketorolac may increase the risk of heart attack and stroke, especially with higher doses or longer treatment durations.
• Bleeding Risk: It can inhibit platelet aggregation, increasing the risk of bleeding, which is particularly concerning in surgical patients.
• Allergic Reactions: Severe allergic reactions, including anaphylaxis, can occur.

Due to these risks, Ketorolac is contraindicated in patients with active peptic ulcer disease, recent gastrointestinal bleeding, advanced kidney disease, or a history of hypersensitivity to NSAIDs. It should also be used with extreme caution in patients with cardiovascular disease or those taking anticoagulants. The strict five-day limit for systemic use is a critical safety measure to mitigate these risks.